Related references
Note: Only part of the references are listed.Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults
Benjamin I. Perry et al.
JAMA PSYCHIATRY (2021)
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Mark R. Libowitz et al.
FRONTIERS IN PSYCHIATRY (2021)
Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial
Christoph U. Correll et al.
WORLD PSYCHIATRY (2020)
Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study
Robert C. Smith et al.
PSYCHOPHARMACOLOGY (2018)
Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
Dongyu Kang et al.
FRONTIERS IN PSYCHIATRY (2018)
Effect of phentermine on weight reduction in a pediatric weight management clinic
J. R. Ryder et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Seyed-Ali Mostafavi et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2017)
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder A Randomized Clinical Trial
Julie R. Larsen et al.
JAMA PSYCHIATRY (2017)
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
Madhubhashinee Dayabandara et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Topiramate, zonisamide and weight loss in children and adolescents prescribed psychiatric medications: A medical record review
Michael Shapiro et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2016)
Phenterrnine, Sibutramine and Affective Disorders
Hoyoung An et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2013)
Correlates of weight gain during long-term risperidone treatment in children and adolescents
Chadi Calarge et al.
Child and Adolescent Psychiatry and Mental Health (2012)
Amantadine for olanzapine-induced weight gain: a systematic review and meta-analysis of randomized placebo-controlled trials
Samir Kumar Praharaj et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2012)
Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
Lawrence Maayan et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2011)
Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic-Induced Weight Gain
Lara K. Ellinger et al.
ANNALS OF PHARMACOTHERAPY (2010)
An Exploration of the Effect of Modafinil on Olanzapine Associated Weight Gain in Normal Human Subjects
James L. Roerig et al.
BIOLOGICAL PSYCHIATRY (2009)
Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity:: A 16-week randomized, double-blind, placebo-controlled trial
Grigori Joffe et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
An overview of obesity in children with psychiatric disorders taking atypical antipsychotics
Lauren Shin et al.
HARVARD REVIEW OF PSYCHIATRY (2008)
Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders
R Canitano
BRAIN & DEVELOPMENT (2005)
Amantadine treatment of psychotropic-induced weight gain in children and adolescents: Case series
BL Gracious et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2002)
Share Paper
